Nisamox Injection
Land: Italien
Sprache: Englisch
Quelle: HMA (Heads of Medicines Agencies)
Fachinformation
(SPC)
03-03-2013
Einige Dokumente für dieses Produkt sind derzeit nicht verfügbar. Sie können eine Anfrage an unseren Kundendienst senden. Wir werden Sie benachrichtigen, sobald wir sie erhalten können.
Anfrage senden.
Anfrage senden.
Wirkstoff:
amoxicillin trihydrate 14 %w/v, Potassium clavulanate 3.5 %w/v
Verfügbar ab:
Norbrook Laboratories Limited
Darreichungsform:
Suspension for injection
Therapiebereich:
Cattle
Berechtigungsdatum:
2011-08-17
Fachinformation
Revised: September 2012
AN: 00536/2012
Page 1 of 9
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nisamox Suspension for Injection (Belgium & UK)
Nisamox Suspension for Injection (Portugal)
Nisamox 175 mg Suspension for Injection (Spain)
Nisinject Suspension for Injection (Italy)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml supplies:
ACTIVE SUBSTANCE:
Amoxicillin (as Amoxicillin trihydrate)
140 mg
Clavulanic acid (as Potassium clavulanate)
35 mg
EXCIPIENTS:
Butylated hydroxyanisole (E320) 0.08 mg
Butylated hydroxytoluene (E321) 0.08 mg
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection.
An off-white to cream oily suspension.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cattle:
Respiratory infections
Soft tissue infections (e.g. joint/navel ill, abscesses etc.)
In Dogs:
Respiratory tract infections, urinary tract infections, skin and soft tissue
infections (e.g. abscesses, pyoderma, anal sacculitis and gingivitis.).
Revised: September 2012
AN: 00536/2012
Page 2 of 9
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to penicillin or other
substances of the beta-lactam group.
Do not use in animals with serious dysfunction of kidneys accompanied by
anuria or oliguria.
Do not use in rabbits, guinea pigs, hamsters or gerbils.
The use of the product is contra-indicated where resistance to the
combination of penicillins or other substances of the beta-lactam group is
known to occur.
4.4 SPECIAL WARNINGS FOR
Lesen Sie das vollständige Dokument
